Australia markets open in 2 hours 38 minutes

Encompass Health Corporation (EHC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
85.45+0.01 (+0.01%)
At close: 04:00PM EDT
85.45 0.00 (0.00%)
After hours: 05:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.60B
Enterprise value 11.39B
Trailing P/E 22.37
Forward P/E 21.74
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.75
Price/book (mrq)4.94
Enterprise value/revenue 2.30
Enterprise value/EBITDA 10.72

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 337.82%
S&P500 52-week change 326.49%
52-week high 387.94
52-week low 357.55
50-day moving average 381.14
200-day moving average 371.57

Share statistics

Avg vol (3-month) 3684.19k
Avg vol (10-day) 3563.13k
Shares outstanding 5100.69M
Implied shares outstanding 6100.69M
Float 899.25M
% held by insiders 11.44%
% held by institutions 199.60%
Shares short (30 Apr 2024) 41.77M
Short ratio (30 Apr 2024) 42.27
Short % of float (30 Apr 2024) 41.98%
Short % of shares outstanding (30 Apr 2024) 41.76%
Shares short (prior month 28 Mar 2024) 42.47M

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 40.70%
Trailing annual dividend rate 30.60
Trailing annual dividend yield 30.70%
5-year average dividend yield 41.48
Payout ratio 415.71%
Dividend date 315 July 2024
Ex-dividend date 401 July 2024
Last split factor 21257:1000
Last split date 301 July 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 7.60%
Operating margin (ttm)15.77%

Management effectiveness

Return on assets (ttm)7.94%
Return on equity (ttm)22.94%

Income statement

Revenue (ttm)4.96B
Revenue per share (ttm)49.77
Quarterly revenue growth (yoy)13.40%
Gross profit (ttm)N/A
EBITDA 1.04B
Net income avi to common (ttm)386.5M
Diluted EPS (ttm)3.82
Quarterly earnings growth (yoy)28.30%

Balance sheet

Total cash (mrq)134.4M
Total cash per share (mrq)1.34
Total debt (mrq)2.92B
Total debt/equity (mrq)121.47%
Current ratio (mrq)1.37
Book value per share (mrq)17.30

Cash flow statement

Operating cash flow (ttm)861.7M
Levered free cash flow (ttm)76.4M